Research / ARDX / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-22-012630 General Corporate
Debt relative to revenue 79th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.debt_to_revenue
5585.26% · OPTIONAL · VALID
Capex intensity 19th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
Operating cash generation 20th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-5901.71% · OPTIONAL · VALID
Revenue growth 9th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.revenue
-92.89% · CORE · VALID
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
745.09% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating margin 19th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
-5941.67% · CORE · VALID
R&D intensity 63th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1891.24% · OPTIONAL · VALID
SBC intensity 81th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
795.30% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/8 normalized Level 3 Jun 30, 2023 7/8 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 319.54%
Current 5585.26%
Delta 5265.72% Capex Intensity Decreased
Previous 18.49%
Current 0.00%
Delta -18.49% Cash Generation Decreased
Previous -1510.85%
Current -5901.71%
Delta -4390.85% Growth Decreased
Previous 33.36%
Current -92.89%
Delta -126.25% Profitability Decreased
Previous -1528.63%
Current -5941.67%
Delta -4413.03% R And D Intensity Increased
Previous 902.64%
Current 1891.24%
Delta 988.60% Sbc Intensity Increased
Previous 119.23%
Current 795.30%
Delta 676.07% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.